Improving Outcomes with Novel Approaches in von Hippel-Lindau Disease: An Expert Review of Emerging Pharmacotherapeutic Strategies

Improving Outcomes with Novel Approaches in von Hippel-Lindau Disease: An Expert Review of Emerging Pharmacotherapeutic Strategies

The goal of this educational activity is to equip and empower oncology pharmacists and nurses with the knowledge, confidence, competence, and tools/resources necessary to recognize clinical hallmarks of VHL and serve vital patient-facing roles across the multidisciplinary treatment continuum, including the safe, effective, and patient-centric implementation of novel pharmacotherapeutics for management of VHL-associated tumors.

  • Provider:Postgraduate Institute for Medicine
  • Start Date: 2024-09-27 05:00:00
  • End Date: 2024-09-27 05:00:00
  • Credit Details: Nursing: 2.0 hours
  • Commercial Support: Source: Merck (Any division) - Amount: 98075.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.